No Detail Found!

Comparison of the Efficacy of Aspirin with Rivaroxaban in Postoperative DVT Prophylaxis after Hip Arthroplasty in patients at tertiary care hospital, Karachi

Author(s)
FAHAD SIDDIQUE JATOI Orthopedic Department, Jinnah Postgraduate Medical Centre,Karachi,Pakistan
MUZAFAR HUSSAIN BURIRO Orthopedic Department, Jinnah Postgraduate Medical Center Karachi,Pakistan
SAJJAD ALI Orthopedic Department, Jinnah Postgraduate Medical Center,karachi.Pakistan
MUHAMMAD YOUNIS Gambat Institute of Medical and Sciences,Pakistan
FAHEEM AHMED Orthopedic Department, Shaheed muhtarma benazir Bhutto institute of trauma Karachi,Pakistan
ARSHAN MUNIR Orthopedic Department, Mayo Hospital,Lahore,Pakistan
Abstract
Patients suffering from severe hip arthritis and osteonecrosis are increasingly turning to total hip arthroplasty (THA) as a treatment option, according to recent research. If deep vein thrombosis (DVT) is not treated properly, it can result in a life-threatening pulmonary embolism as well as other potentially life-threatening consequences (PE). Aim: To compare the efficacy of aspirin with rivaroxaban in postoperative dvt prophylaxis after hip arthroplasty in patients at tertiary care hospital, Karachi Methodology: The College of Physicians and Surgeons of Pakistan approved this study prior to its completion. The Department of Orthopedics at JPMC, Karachi, chose those who had complete hip arthroplasty for the study. The school's ethical committee approved the study before it could begin. Before participating in the trial, all patients signed an informed consent form granting them permission to do so. Results: Patients from JPMC Karachi's Department of Orthopedics were included in the study. They were aged 49 to 75. Travel time to the hospital was an average of 58.878.19 years. They were aged 49 to 75. For every month, hour, and day spent in hospital, there are 14.416.14. Eighty people used aspirin, 32(40%) were 40-60 and 48(60%) were 61-75. In the rivaroxaban group, 40 patients (50%) were 40-60, and (61-75). The aspirin group had 80 patients, 38 male (47%) and 42 female (42%) (52.5%). One hundred and twenty-five patients (68.8%) were on rivaroxaban (31.2%). Conclusions: People who have a spontaneous venous thromboembolism should not be given long-term thromboprophylaxis after taking oral anticoagulants until more research is done. It is very important to figure out what DVY risk factors are in order to come up with preventative measures that are both safe and affordable. People can live longer if they get an early diagnosis and get treatment quickly, so they can live longer. High-quality, large-scale studies must be done before a conclusion can be drawn.
Publication Details
Page(s) 18-21
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 05, Year: 2022

Request the full text from PASTIC

Keywords
Arthroplasty, Thromboembolism, DVY risk, thromboprophylaxis
References
Meller MM,Toossi N,Johanson NA,Gonzalez MH,Son M-S .2016 .Risk and cost of 90-day complications in morbidlyand superobese patients after total knee arthroplasty. J Arthroplasty, 31(10) : 2091-98.
Judge A,Cooper C,Williams S,Dreinhoefer K .2010 .Patient reported outcomes one year after primary hipreplacement in a European Collaborative Cohort. ArthritisCare Res, 62 : 480-8.
Chan YK,Chiu KY,Cheng SW,Ho P. .2004 .The incidence of deepvein thrombosis in elderly Chinese suffering hip fractures islow without prohlyaxis: a prospective study using serialduplex Ultrasound. J Orthop Surg, 12 : 178-83.
Aziz I. .2005 .Frequency of deep vein thrombosis in high risksurgical patients. J Coll Physicians Surg Pak, 15 : 299-01.
Kucher N. .2011 .Clinical practice. Deep-vein thrombosis of theupper extremities. N Engl J Med, 364 : 861-69.
Cohen AT,Asia-Pacific Thrombosis Advisory Board. AsiaPacific Thrombosis Advisory AT .2010 .Board consensus paper onprevention of venous thromboembolism after majororthopaedic surgery. Thromb Haemost, 104 : 919-30.
Piovella F,Wang CJ,Lu H,Lee K,Lee LH,Lee WC .2005 .Deep-vein thrombosis rates after major orthopedic surgeryin Asia: an epidemiological study based on postoperativescreening with centrally adjudicated bilateral venography. J Thromb Haemost, 3 : 2664-70.
Warwick D .2012 .Prevention of venous thromboembolism in totalknee and hip replacement. Circulation, 125 : 2151-55.
Ahmad T,Zaman AU,Ahmad I,Akram R,Aziz A . .Frequency and risk factors for deep vein thrombosis afterorthopaedic surgery. Pak J Med Health Sci2016;, 10(3) : 744-49.
Papadopoulos DV,Kostas‐Agnantis I,Gkiatas I,Ziara P,Korompilias AV .2017 .The role of new oralanticoagulants in orthopaedics: an update of recent evidence. Eur J Orthop Surg Traumatol, 27 : 573-82.
Feng W,Wu K .2015 .Oral direct factor Xa inhibitor versusenoxaparin for thromboprophylaxis after hip or kneearthroplasty: systemic review, traditional meta‐analysis,dose‐response meta‐analysis and network meta‐analysis. Thromb Res, 136 : 1133-44.
Ye Jiajing CZ,Haizhao W,Lingjun J,Zhong Z,Tsunami C,Zhenghua H C .2017 .Safety of rivaroxaban combined with aspirinafter total hip and knee arthroplasty and its effectivenessin prevention of cerebral infarction. Chin J Bone JointInjury, 32 : 1053-55.
Tang Y,Wang K,Shi Z,Yang P,Dang X. .2017 .A RCT study of Rivaroxaban, low‐molecular‐weight heparin, and sequential Medication regimens for the prevention of venous Thrombosis after internal fixation of hip fracture. Biomed Pharmacother, 92 : 982-88.
Anderson DR,Dunbar MJ,Bohm ER .2013 .Aspirin versus low‐Molecular‐weight heparin for extended venous Thromboembolism prophylaxis after total hip arthroplasty: A randomized trial. Ann Intern Med, 158 : 800-06.
Huang Q,Xing SX,Zeng Y,Si HB,Zhou ZK,Shen B . .Comparison of the efficacy and safety of aspirin and Rivaroxaban following enoxaparin treatment for prevention of venous thromboembolism after hip fracture surgery. Orthop Surg, 11(5) : 88694.
Piovella F,Wang CJ,Lu H .2005 .vein thrombosis rates After major orthopedic surgery in Asia. An epidemiological Study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost, 3 : 2664-2670.
Yu HT,Dylan ML,Lin J,Dubois RW .2007 .Hospitals' compliance With prophylaxis guidelines for venous Thromboembolism. Am J Health Syst Pharm, 64 : 69.
Eichinger S,Kyrle PA .2004 .Prevention of deep vein thrombosis in orthopedic surgery. Eur J Med Res, 9 : 112-118.
Association CO,Quinlan DJ,Eikelboom JW,Dahl OE,Eriksson BI,Sidhu PS .2007 .Association between asymptomatic deep veins thrombosis detected by venography and symptomatic Venous thromboembolism in patients undergoing elective Hip or knee surgery. J Thromb Haemost, 5 : 1438-1443.
0

Citations

0

Downloads

63

Views